VA Office of Research and Development
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, VA Office of Research and Development sits in the top decile of US sponsors by registered trial count (#11 of 15,751 sponsors by registered trial count).
VA Office of Research and Development: 1,668 sponsored US clinical trials, 291 recruiting.
VA Office of Research and Development sponsors 1,668 registered US clinical trials on ClinicalTrials.gov, 291 of them currently recruiting, and 1,108 completed. 124 of these trials are in Phase 3-4 (later-stage) and 236 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is PTSD, with 28 trials.
Top-decile sponsor footprint
VA Office of Research and Development ranks in the top decile of sponsors by registered trial count (#11 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,668 total, page 25 of 34
The Efficacy of CBT-I in Alcoholics & Its Effects on Remission & Relapse
NCT01987089
Perioperative Post-Prostatectomy Incontinence Home Telehealth Program
NCT01960998
Effect of Levodopa on Postural Motor Learning in Parkinson Disease
NCT02239978
Immune Function and Muscle Adaptations to Resistance Exercise in Older Adults
NCT02261961
Proactive Outreach for Smokers in VA Mental Health
NCT01737281
Self-management to Improve Function Following Amputation
NCT02163811
Use of Track Health Function of the MyHealthevet Personal Health Record
NCT02921425
Internet-based Behavioral Pain Management
NCT01918189
Oxygen Versus PAP for Sleep Apnea in Heart Failure
NCT01807897
Rehabilitating Corticospinal Control of Walking
NCT02132650
Reducing the Burden of Depression Related Disability
NCT02111811
Implementation of Women's Health Patient Aligned Care Teams
NCT02039856
Citalopram Effects on Craving and Dopamine Receptor Availability in Alcoholics
NCT01657760
Functional Movement Retraining After Hip Replacement
NCT01878175
Improving Functions in MTBI Patients With Headache by rTMS
NCT01948947
Seven vs. 14 Days Treatment for Male Urinary Tract Infection
NCT01994538
Metformin and Muscle in Insulin-resistant Older Veterans
NCT01804049
Checklist to Prevent MRSA Surgical Site Infections
NCT02216227
Pharmacogenetic Trial of Doxazosin for Treatment of Cocaine Abuse
NCT01953432
Evaluation of Videoconferencing Versus Telephone Genetic Counseling
NCT02108977
Enhancing Delivery of Problem Solving Therapy Using SmartPhone Technology
NCT01891734
Executive Functioning in TBI From Rehabilitation to Social Reintegration: COMPASS
NCT01816061
Speech Therapy for Aphasia: Comparing Two Treatments
NCT02153710
Brain Biomarkers of Response to Treatment for Apraxia of Speech
NCT02046941
Veterans Coping Long-term With Active Suicide
NCT01894841
VA Cultivating Access to Resources, Education, and Skills for Dementia Caregivers
NCT02106065
Weight Loss Intervention for Individuals With Lower Extremity Amputation
NCT02085785
Helping Invested Families Improve Veterans Experiences Study
NCT01777490
Understanding the Exercise-Hypertension Paradox
NCT02034422
Supportive Care for Patients Newly Diagnosed With Lung Cancer
NCT01883986
Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence
NCT01609842
Comprehensive vs. Assisted Management of Mood and Pain Symptoms
NCT01757301
Translation of Eye Movement Reading Training to Clinical Practice
NCT01853930
A Simplified Patient-Centered Educational Tool for Improved Hearing-Aid Outcomes
NCT01940705
Novel Treatment of Comorbid Insomnia and Sleep Apnea in Older Veterans
NCT02027558
Increasing Engagement in Evidence-Based PTSD Therapy for Primary Care Veterans
NCT01984515
Veterans Individual Placement and Support Towards Advancing Recovery
NCT01817712
CPT and Smoking Cessation
NCT01901848
Mindfulness-Based Cognitive Therapy for Suicide Prevention
NCT01872338
Genomics of Posttraumatic Stress Disorder in Veterans
NCT02256644
Advanced Comprehensive Diabetes Care for Veterans With Poorly-Controlled Diabetes
NCT01778751
Discharge Information and Support for Patients Receiving Outpatient Care in the Emergency Department
NCT01717976
Evaluating the CG ASSIST Program for Caregiving Dyads
NCT02021565
Combined Cognitive and Gait Training
NCT02362282
Buprenorphine vs. Opioid Dose Escalation Among Patients With Chronic Pain
NCT01875848
An Educational Intervention for Type 2 Diabetes Patients
NCT01671345
Abstinence Reinforcement Therapy (ART) for Rural Veteran Smokers
NCT01723163
Evaluating Two Types of Cognitive Training in Veterans With Schizophrenia
NCT01891721
Maintaining Cognitive Health in Aging Veterans
NCT02023944
Mitigation of Radiation Pneumonitis and Fibrosis
NCT01754909
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 89 |
| Phase 2 | 147 |
| Phase 3 | 55 |
| Phase 4 | 69 |
Therapeutic Areas
What is open in the VA Office of Research and Development pipeline
291 recruiting of 1,668 indexed (17% open); 1,108 completed (66%).
Phase mix: 124 late (III/IV) vs 236 early (I/II) (early-phase heavy).
Top condition: PTSD (28 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.